The novel Candida albicans transporter Dur31 is a multi-stage pathogenicity factor

PLoS Pathogens

Volumn 8, Issue 3, 2012, Pages

  Mayer, François L ^a   Wilson, Duncan ^a   Jacobsen, Ilse D ^a   Miramón, Pedro ^a   Große, Katharina ^a   Hube, Bernhard ^a,b  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FUNGAL PROTEIN; HISTATIN 5; SPERMIDINE; TRANSPORTER DUR31; UNCLASSIFIED DRUG; HISTATIN; HTN3 PROTEIN, HUMAN; VIRULENCE FACTOR;

ALKALINIZATION; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOTOXICITY; FUNGAL GENE; FUNGAL VIRULENCE; FUNGUS MUTANT; GENE DELETION; GENE FUNCTION; GENE INACTIVATION; GENETIC ANALYSIS; HOMOZYGOSITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUTH INJURY; MOUTH MUCOSA; NEUTROPHIL; NONHUMAN; PROTEIN DOMAIN; SODIUM TRANSPORT; THRUSH; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; CANDIDIASIS; CELL CULTURE; COMPUTER SIMULATION; DISEASE MODEL; EPITHELIUM; FEMALE; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY;

CANDIDA ALBICANS; FUNGI;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DISEASE MODELS, ANIMAL; EPITHELIUM; FEMALE; FUNGAL PROTEINS; GENE DELETION; GENE KNOCKDOWN TECHNIQUES; HISTATINS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; NEUTROPHILS; VIRULENCE FACTORS;

EID: 84861205386     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002592     Document Type: Article

References (75)

1. Odds FC, (1988) Candida and Candidosis London Bailliere Tindall.
2. Williams D, Lewis M, (2011) Pathogenesis and treatment of oral candidosis. J Oral Microbiol 3 doi:10.3402/jom.v3i0.5771.
3. ten Cate JM, Klis FM, Pereira-Cenci T, Crielaard W, de Groot PW, (2009) Molecular and cellular mechanisms that lead to Candida biofilm formation. J Dent Res 88: 105-115.
4. Fidel PL Jr, (2006) Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv Dent Res 19: 80-84.
5. Klein RS, Harris CA, Small CB, Moll B, Lesser M, et al. (1984) Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 311: 354-358.
6. Lal K, Pollock JJ, Santarpia RP 3rd, Heller HM, Kaufman HW, et al. (1992) Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. J Acquir Immune Defic Syndr 5: 904-914.
7. Challacombe SJ, Naglik JR, (2006) The effects of HIV infection on oral mucosal immunity. Adv Dent Res 19: 29-35.
8. Martin R, Wachtler B, Schaller M, Wilson D, Hube B, (2011) Host-pathogen interactions and virulence-associated genes during Candida albicans oral infections. Int J Med Microbiol 301: 417-422.
9. Zakikhany K, Naglik JR, Schmidt-Westhausen A, Holland G, Schaller M, et al. (2007) In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell Microbiol 9: 2938-2954.
10. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
11. Dalle F, Wachtler B, L'Ollivier C, Holland G, Bannert N, et al. (2010) Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 12: 248-271.
12. Wachtler B, Wilson D, Haedicke K, Dalle F, Hube B, (2011) From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One 6: e17046.
13. Zhu W, Filler SG, (2010) Interactions of Candida albicans with epithelial cells. Cell Microbiol 12: 273-282.
14. Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, et al. (2007) Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5: e64.
15. Sun JN, Solis NV, Phan QT, Bajwa JS, Kashleva H, et al. (2010) Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog 6: e1001181.
16. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
17. Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, et al. (2011) The Fungal Pathogen Candida albicans Autoinduces Hyphal Morphogenesis by Raising Extracellular pH. MBio 2: e00055-11.
18. Tsai PW, Yang CY, Chang HT, Lan CY, (2011) Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS One 6: e17755.
19. Bals R, Wilson JM, (2003) Cathelicidins-a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 60: 711-720.
20. Klotman ME, Chang TL, (2006) Defensins in innate antiviral immunity. Nat Rev Immunol 6: 447-456.
21. Peters BM, Zhu J, Fidel PL Jr, Scheper MA, Hackett W, et al. (2010) Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection. FEMS Yeast Res 10: 597-604.
22. Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, et al. (1998) Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 273: 20438-20447.
23. Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, et al. (2005) Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 56: 397-415.
24. Perlroth J, Choi B, Spellberg B, (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45: 321-346.
25. Calderone RA, (2002) Candida and Candidiasis Washington D.C. ASM Press.
26. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP, (1998) National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 31: 327-332.
27. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309-317.
28. Martin R, Moran GP, Jacobsen ID, Heyken A, Domey J, et al. (2011) The Candida albicans-specific gene EED1 encodes a key regulator of hyphal extension. PLoS One 6: e18394.
29. Phan QT, Belanger PH, Filler SG, (2000) Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68: 3485-3490.
30. Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, et al. (2005) Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol 7: 499-510.
31. Sumrada R, Gorski M, Cooper T, (1976) Urea transport-defective strains of Saccharomyces cerevisiae. J Bacteriol 125: 1048-1056.
32. ElBerry HM, Majumdar ML, Cunningham TS, Sumrada RA, Cooper TG, (1993) Regulation of the urea active transporter gene (DUR3) in Saccharomyces cerevisiae. J Bacteriol 175: 4688-4698.
33. Uemura T, Kashiwagi K, Igarashi K, (2007) Polyamine uptake by DUR3 and SAM3 in Saccharomyces cerevisiae. J Biol Chem 282: 7733-7741.
34. Navarathna DH, Das A, Morschhaeuser J, Nickerson KW, Roberts DD, (2010) Dur3 is the major urea transporter in Candida albicans and is co-regulated with the urea amidolyase Dur1,2. Microbiology 157: 270-9.
35. Kumar R, Chadha S, Saraswat D, Bajwa JS, Li RA, et al. (2011) Histatin 5 uptake by Candida albicans utilizes the polyamine transporters Dur3 and Dur31. J Biol Chem 286: 43748-58.
36. Navarro-Garcia F, Eisman B, Fiuza SM, Nombela C, Pla J, (2005) The MAP kinase Mkc1p is activated under different stress conditions in Candida albicans. Microbiology 151: 2737-2749.
37. Herrero AB, Lopez MC, Garcia S, Schmidt A, Spaltmann F, et al. (1999) Control of filament formation in Candida albicans by polyamine levels. Infect Immun 67: 4870-4878.
38. Ghosh S, Navarathna DH, Roberts DD, Cooper JT, Atkin AL, et al. (2009) Arginine-induced germ tube formation in Candida albicans is essential for escape from murine macrophage line RAW 264.7. Infect Immun 77: 1596-1605.
39. Kumamoto CA, Vinces MD, (2005) Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol 7: 1546-1554.
40. Thewes S, Kretschmar M, Park H, Schaller M, Filler SG, et al. (2007) In vivo and ex vivo comparative transcriptional profiling of invasive and non-invasive Candida albicans isolates identifies genes associated with tissue invasion. Mol Microbiol 63: 1606-1628.
41. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, et al. (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5: e1000639.
42. Nathan C, (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6: 173-182.
43. Jung H, (2002) The sodium/substrate symporter family: structural and functional features. FEBS Lett 529: 73-77.
44. Jang WS, Bajwa JS, Sun JN, Edgerton M, (2010) Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans. Mol Microbiol 77: 354-370.
45. Torres SR, Garzino-Demo A, Meiller TF, Meeks V, Jabra-Rizk MA, (2009) Salivary histatin-5 and oral fungal colonisation in HIV+ individuals. Mycoses 52: 11-15.
46. Mochon AB, Liu H, (2008) The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm. PLoS Pathog 4: e1000190.
47. Li XS, Reddy MS, Baev D, Edgerton M, (2003) Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J Biol Chem 278: 28553-28561.
48. Li XS, Sun JN, Okamoto-Shibayama K, Edgerton M, (2006) Candida albicans cell wall ssa proteins bind and facilitate import of salivary histatin 5 required for toxicity. J Biol Chem 281: 22453-22463.
49. Skrzypek MS, Arnaud MB, Costanzo MC, Inglis DO, Shah P, et al. (2010) New tools at the Candida Genome Database: biochemical pathways and full-text literature search. Nucleic Acids Res 38: D428-432.
50. Wilson D, Thewes S, Zakikhany K, Fradin C, Albrecht A, et al. (2009) Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res 9: 688-700.
51. Park H, Liu Y, Solis N, Spotkov J, Hamaker J, et al. (2009) Transcriptional responses of candida albicans to epithelial and endothelial cells. Eukaryot Cell 8: 1498-1510.
52. Chiang LY, Sheppard DC, Bruno VM, Mitchell AP, Edwards JE Jr, et al. (2007) Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis. Cell Microbiol 9: 233-245.
53. Filler SG, Sheppard DC, (2006) Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2: e129.
54. Edgerton M, Koshlukova SE, Araujo MW, Patel RC, Dong J, et al. (2000) Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother 44: 3310-3316.
55. Filler SG, Swerdloff JN, Hobbs C, Luckett PM, (1995) Penetration and damage of endothelial cells by Candida albicans. Infect Immun 63: 976-983.
56. Sanchez AA, Johnston DA, Myers C, Edwards JE Jr, Mitchell AP, et al. (2004) Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun 72: 598-601.
57. Schwan WR, Coulter SN, Ng EY, Langhorne MH, Ritchie HD, et al. (1998) Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models. Infect Immun 66: 567-572.
58. Igarashi K, Kashiwagi K, (2010) Characteristics of cellular polyamine transport in prokaryotes and eukaryotes. Plant Physiol Biochem 48: 506-512.
59. Sun JN, Li W, Jang WS, Nayyar N, Sutton MD, et al. (2008) Uptake of the antifungal cationic peptide Histatin 5 by Candida albicans Ssa2p requires binding to non-conventional sites within the ATPase domain. Mol Microbiol 70: 1246-1260.
60. Vylkova S, Sun JN, Edgerton M, (2007) The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides. Purinergic Signal 3: 91-97.
61. Meiller TF, Hube B, Schild L, Shirtliff ME, Scheper MA, et al. (2009) A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS One 4: e5039.
62. Palkova Z, Devaux F, Icicova M, Minarikova L, Le Crom S, et al. (2002) Ammonia pulses and metabolic oscillations guide yeast colony development. Mol Biol Cell 13: 3901-3914.
63. Bensen ES, Martin SJ, Li M, Berman J, Davis DA, (2004) Transcriptional profiling in Candida albicans reveals new adaptive responses to extracellular pH and functions for Rim101p. Mol Microbiol 54: 1335-1351.
64. Lis M, Liu TT, Barker KS, Rogers PD, Bobek LA, (2010) Antimicrobial peptide MUC7 12-mer activates the calcium/calcineurin pathway in Candida albicans. FEMS Yeast Res 10: 579-586.
65. Gola S, Martin R, Walther A, Dunkler A, Wendland J, (2003) New modules for PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region. Yeast 20: 1339-1347.
66. Wilson RB, Davis D, Mitchell AP, (1999) Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol 181: 1868-1874.
67. Walther A, Wendland J, (2003) An improved transformation protocol for the human fungal pathogen Candida albicans. Curr Genet 42: 339-343.
68. Murad AM, Lee PR, Broadbent ID, Barelle CJ, Brown AJ, (2000) CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast 16: 325-327.
69. Dong J, Vylkova S, Li XS, Edgerton M, (2003) Calcium blocks fungicidal activity of human salivary histatin 5 through disruption of binding with Candida albicans. J Dent Res 82: 748-752.
70. Ruissen AL, Groenink J, Helmerhorst EJ, Walgreen-Weterings E, Van't Hof W, et al. (2001) Effects of histatin 5 and derived peptides on Candida albicans. Biochem J 356: 361-368.
71. Helmerhorst EJ, Breeuwer P, van't Hof W, Walgreen-Weterings E, Oomen LC, et al. (1999) The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem 274: 7286-7291.
72. Liu H, Kohler J, Fink GR, (1994) Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726.
73. Kumamoto CA, (2005) A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc Natl Acad Sci U S A 102: 5576-5581.
74. Rupniak HT, Rowlatt C, Lane EB, Steele JG, Trejdosiewicz LK, et al. (1985) Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst 75: 621-635.
75. Gillum AM, Tsay EY, Kirsch DR, (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.